References
Rybak MJ, McGrath BJ. Combination antibacterial therapy for bacterial infections: guidelines for the clinician. Drugs 1996 Sep; 52(3): 390–405
Streptograrnins may be useful in the treatment of resistant Grampositive infections. Drug Ther Perspect 1996 Dec 9; 8(12): 6–8
Schaberg DR, Cluver DH, Gaynes RP. Major trends in the microbial etiology of nosocornia1 infection. Am J Med 1991; 91:Suppl. 3B: 72S–5S
Kovorik JA, Yu VL. Antimicrobial therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 2167–72
Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540–6
Brouqui P, Rousseau MC, Stein A, et al. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 1995; 39: 2423–5
Chambers HF, Miller RT, Newmann MD. Right-sided staphylococcus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988; 109: 619–24
Leclercq R, Bingen E, Su QH, et al. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci. Antimicrob Agents Chemother 1991; 35: 92–8
Moellering RC, Eliopoulos GM, Allan ID. Beta-lactam aminoglycoside combinations interactions and their mechanisms. Am J Med 1986; 80 Suppl. 5C: 30–4
Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis 1969; 119: 597–624
Foran RM, Brett JL, Wulf PH. Evaluating the cost impact of intravenous antibiotic dosing frequencies. FICP 1991; 25: 546–51
Rights and permissions
About this article
Cite this article
Combination antibacterial therapy: appropriate in certain situations. Drugs Ther. Perspect 9, 10–13 (1997). https://doi.org/10.2165/00042310-199709050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199709050-00004